Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for hip and knee osteoarthritis
NL-OMON59952Phase 3Recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Jan 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA), knee osteoarthritis (OA) and hip osteoarthritis comparing Colchicine with Placebo (2 arms). Primary endpoint: Time to first total knee or hip replacement. Started Jan 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
osteoarthritis (OA)knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on NL-OMON59952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59952.